Summary

The leading business intelligence provider, has released its latest research, “Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline”, which provides an insight into the global biotechnology industry and analyzes the competitive positioning of the top 10 companies in the industry. This pharmaceutical and healthcare report estimates the market size of the global biotechnology industry and its future prospects. It benchmarks the leading companies in the biotechnology industry on selected parameters to analyze their competitive positioning in the market. The report analyzes the future landscape of the biotechnology industry by forecasting the revenues of leading companies to 2012. For each company the report analyzes the financial strength, product portfolio, pipeline strength and therapeutic focus of its R&D activities. It critically examines the strengths and weaknesses of individual companies and the opportunities and threats facing them.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The report analyses the competitive landscape of the biotechnology industry, R&D strategies and pipeline of the top 10 players, and strengths, weaknesses, opportunities and threats facing these companies. Its scope includes
- Market size of the global biotechnology industry and coverage of the changing competitive landscape from 2008 to 2012.
- Review of key industry drivers and restraints which are likely to impact the global biotechnology industry in the future.
- Analysis of the competitive positioning of the top 10 biotechnology companies globally.
- Analysis of pipeline products in the global biotech market by therapy area like cancer, infectious diseases, respiratory disorders, autoimmune disorders, and product classes.
- Financial analysis including annual revenues of top 10 companies from 2004 to 2008, with forecasts to 2012.
- SWOT analysis, DuPont analysis and financial benchmarking of the top 10 biotech companies.
- Analysis of the therapeutic focus, marketed products and product pipeline of top 10 biotech companies.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop a clear knowledge and understanding of the competitive landscape and how this will change in the coming years.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
- Make more informed business decisions from the insightful and in-depth analysis of the key strategies to be followed by competitors.
- Effectively plan your investment strategies by identifying companies with maximum investment potential.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities."

1
1 4
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 GBI Research Report Guidance 16
3 Global Biotechnology Industry – Market Characterization 17
3.1 Global Biotechnology Industry – Market Size 17
3.2 Top 10 Companies – Market Forecast 18
3.3 Therapeutic Focus of the Biotechnology Industry 20
3.4 Global Biotechnology Industry – Growth Drivers and Restraints 22
3.4.1 Growth Drivers 22
3.4.2 Restraints 23
4 Top 10 Biotechnology Companies – Competitive Landscape 24
4.1 Competitive Landscape Framework 24
4.2 Financial Benchmarking 25
4.2.1 Earnings per Share 26
4.2.2 Net Profit Margin 26
4.2.3 Current Ratio 27
4.2.4 Debt to Equity ratio 27
4.2.5 Asset Turnover Ratio 28
4.3 R&D Productivity Framework 28
5 Global Biotechnology Industry – Strategic Consolidations 30
5.1 Pharma Biotech Space – Deals Analysis (2008) 30
5.2 Increasing Interest of Big Pharma Companies in the Biotech Industry 31
6 Top 10 Biotechnology Companies – Amgen 33
6.1 Company Overview 33
6.1.1 Introduction 33
6.1.2 Business Description 33
6.2 Strategic Positioning 34
6.2.1 SWOT Analysis 34
6.3 Financial Analysis 36
6.3.1 Revenue Analysis and Forecasts 36
6.3.2 Ratio Analysis 39
6.3.3 DuPont Analysis 43
6.4 Marketed Products 44
6.4.1 Key Marketed Products 44
6.5 R&D Strategies 45
6.5.1 Therapeutic Focus 45
6.5.2 R&D Productivity 46
6.6 Product Pipeline 47
6.6.1 Overview 47
6.6.2 Key Pipeline Products 48
6.7 Licensing Agreements 49
6.7.1 Overview 49
7 Top 10 Biotechnology Companies – Genentech (Roche) 50
7.1 Company Overview 50
7.1.1 Introduction 50
7.1.2 Business Description 50
7.2 Strategic Positioning 51
7.2.1 SWOT Analysis 51
7.3 Financial Analysis 52
7.3.1 Revenue Analysis and Forecasts 52
7.3.2 Ratio Analysis 55
7.3.3 DuPont Analysis 59
7.4 Marketed Products 60
7.4.1 Key Marketed Products 60
7.5 R&D Strategies 61
7.5.1 Therapeutic Focus 61
7.5.2 R&D Productivity 61
7.6 Product Pipeline 62
7.6.1 Overview 62
7.6.2 Key Pipeline Products 64
7.7 Licensing Agreements 64
7.7.1 Overview 64
8 Top 10 Biotechnology Companies – Gilead Sciences 66
8.1 Company Overview 66
8.1.1 Introduction 66
8.1.2 Business Description 66
8.2 Strategic Positioning 67
8.2.1 SWOT Analysis 67
8.3 Financial Analysis 68
8.3.1 Revenue Analysis and Forecasts 68
8.3.2 Ratio Analysis 71
8.3.3 DuPont Analysis 75
8.4 Marketed Products 76
8.4.1 Key Marketed Products 76
8.5 R&D Strategies 76
8.5.1 Therapeutic Focus 76
8.5.2 R&D Productivity 77
8.6 Product Pipeline 78
8.6.1 Overview 78
8.6.2 Key Pipeline Products 79
8.7 Licensing Agreements 79
8.7.1 Overview 79
9 Top 10 Biotechnology Companies – UCB Pharma 80
9.1 Company Overview 80
9.1.1 Introduction 80
9.1.2 Business Description 80
9.2 Strategic Positioning 81
9.2.1 SWOT Analysis 81
9.3 Financial Analysis 82
9.3.1 Revenue Analysis and Forecasts 82
9.3.2 Ratio Analysis 85
9.3.3 DuPont Analysis 89
9.4 Marketed Products 90
9.4.1 Key Marketed Products 90
9.5 R&D Strategies 90
9.5.1 Therapeutic Focus 90
9.5.2 R&D Productivity 90
9.6 Product Pipeline 92
9.6.1 Overview 92
9.6.2 Key Pipeline Products 93
9.7 Licensing Agreements 93
9.7.1 Overview 93
10 Top 10 Biotechnology Companies – Genzyme 94
10.1 Company Overview 94
10.1.1 Introduction 94
10.1.2 Business Description 94
10.2 Strategic Positioning 95
10.2.1 SWOT Analysis 95
10.3 Financial Analysis 97
10.3.1 Revenue Analysis and Forecasts 97
10.3.2 Ratio Analysis 99
10.3.3 DuPont Analysis 102
10.4 Marketed Products 103
10.4.1 Key Marketed Products 103
10.5 R&D Strategies 104
10.5.1 Therapeutic Focus 104
10.5.2 R&D Productivity 105
10.6 Product Pipeline 106
10.6.1 Overview 106
10.6.2 Key Pipeline Products 107
10.7 Licensing Agreements 107
10.7.1 Overview 107
11 Top 10 Biotechnology Companies – Biogen Idec 109
11.1 Company Overview 109
11.1.1 Introduction 109
11.1.2 Business Description 109
11.2 Strategic Positioning 110
11.2.1 SWOT Analysis 110
11.3 Financial Analysis 111
11.3.1 Revenue Analysis and Forecasts 111
11.3.2 Ratio Analysis 114
11.3.3 DuPont Analysis 118
11.4 Marketed Products 119
11.4.1 Key Marketed Products 119
11.5 R&D Strategies 119
11.5.1 Therapeutic Focus 119
11.5.2 R&D Productivity 120
11.6 Product Pipeline 121
11.6.1 Overview 121
11.6.2 Key Pipeline Products 122
11.7 Licensing Agreements 122
11.7.1 Overview 122
12 Top 10 Biotechnology Companies – CSL Limited 123
12.1 Company Overview 123
12.1.1 Introduction 123
12.1.2 Business Description 123
12.2 Strategic Positioning 124
12.2.1 SWOT Analysis 124
12.3 Financial Analysis 125
12.3.1 Revenue Analysis and Forecasts 125
12.3.2 Ratio Analysis 128
12.3.3 DuPont Analysis 132
12.4 Marketed Products 133
12.4.1 Key Marketed Products 133
12.5 R&D Strategies 133
12.5.1 Therapeutic Focus 133
12.5.2 R&D Productivity 134
12.6 Product Pipeline 135
12.6.1 Overview 135
12.6.2 Key Pipeline Products 135
12.7 Licensing Agreements 136
12.7.1 Overview 136
13 Top 10 Biotechnology Companies – Celgene 137
13.1 Company Overview 137
13.1.1 Introduction 137
13.1.2 Business Description 137
13.2 Strategic Positioning 138
13.2.1 SWOT Analysis 138
13.3 Financial Analysis 139
13.3.1 Revenue Analysis and Forecasts 139
13.3.2 Ratio Analysis 141
13.3.3 DuPont Analysis 144
13.4 Marketed Products 145
13.4.1 Key Marketed Products 145
13.5 R&D Strategies 146
13.5.1 Therapeutic Focus 146
13.5.2 R&D Productivity 146
13.6 Product Pipeline 148
13.6.1 Overview 148
13.6.2 Key Pipeline Products 149
13.7 Licensing Agreements 149
13.7.1 Overview 149
14 Top 10 Biotechnology Companies – Cephalon 150
14.1 Company Overview 150
14.1.1 Introduction 150
14.1.2 Business Description 150
14.2 Strategic Positioning 151
14.2.1 SWOT Analysis 151
14.3 Financial Analysis 152
14.3.1 Revenue Analysis and Forecasts 152
14.3.2 Ratio Analysis 154
14.3.3 DuPont Analysis 158
14.4 Marketed Products 158
14.4.1 Key Marketed Products 158
14.5 R&D Strategies 159
14.5.1 Therapeutic Focus 159
14.5.2 R&D Productivity 159
14.6 Product Pipeline 161
14.6.1 Overview 161
14.6.2 Key Pipeline Products 162
14.7 Licensing Agreements 162
14.7.1 Overview 162
15 Top 10 Biotechnology Companies – Actelion 163
15.1 Company Overview 163
15.1.1 Introduction 163
15.1.2 Business Description 163
15.2 Strategic Positioning 164
15.2.1 SWOT Analysis 164
15.3 Financial Analysis 165
15.3.1 Revenue Analysis and Forecasts 165
15.3.2 Ratio Analysis 166
15.3.3 DuPont Analysis 171
15.4 Marketed Products 172
15.4.1 Key Marketed Products 172
15.5 R&D Strategies 172
15.5.1 Therapeutic Focus 172
15.5.2 R&D Productivity 172
15.6 Product Pipeline 174
15.6.1 Overview 174
15.6.2 Key Pipeline Products 174
15.7 Licensing Agreements 175
15.7.1 Overview 175
16 Top 10 Biotechnology Companies – Appendix 176
16.1 Market Definitions 176
16.2 Abbreviations 178
16.3 Research Methodology 178
16.3.1 Coverage 179
16.3.2 Secondary Research 179
16.3.3 Primary Research 180
16.3.4 Expert Panel Validation 180
16.4 Contact Us 180
16.5 Disclaimer 180
16.6 Sources 181

"1.1 List of Tables
Table 1: Top 10 Biotechnology Companies, Global, Annual Revenues, ($m), 2008 17
Table 2: Global, Top 25 Biologic Drugs by Annual Sales. 2008 18
Table 3: Top 10 Biotechnology Companies, Global, Revenue Forecast, ($m), 2008-2012 19
Table 4: Top 10 Biotechnology Compan